FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

400673000: Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1768594016 Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT core module
    1779899014 Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial en Synonym Active Only initial character case insensitive SNOMED CT core module
    1787308017 Diatrizoate meglumine 30% injection en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial Is a Product containing amidotrizoate (medicinal product) false Inferred relationship Existential restriction modifier
    Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial Has active ingredient Amidotrizoate false Inferred relationship Existential restriction modifier
    Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial Is a Product containing iodine AND/OR iodine compound false Inferred relationship Existential restriction modifier
    Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial Is a Product containing meglumine diatrizoate false Inferred relationship Existential restriction modifier
    Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial Has active ingredient Iodine false Inferred relationship Existential restriction modifier
    Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial Has active ingredient Meglumine amidotrizoate false Inferred relationship Existential restriction modifier
    Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial Has active ingredient Iodine compound false Inferred relationship Existential restriction modifier
    Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
    Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial Has active ingredient Iodine AND/OR iodine compound false Inferred relationship Existential restriction modifier
    Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial Is a Product manufactured as parenteral dose form false Inferred relationship Existential restriction modifier
    Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
    Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial Is a Product containing meglumine diatrizoate in parenteral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start